Skip to main content

Novavax charges ahead with $200M in fresh capital — and a familiar face on its board

The developments follow the company’s preparations to sell up to $250 million in common stock less than a month ago.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.